Skip to content
S6909Senate2023-2024 SessionSame asA7795

Let Pharmacists Certify Cannabis

Official title

“Relates to certification by pharmacists of patients using medical cannabis”

Sponsor James SkoufisSD-42+1 co-sponsorAffects Health
Status
In Senate Committee
Health
Impact
6/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill allows pharmacists at registered cannabis dispensaries in New York to certify patients for medical cannabis use after completing required training.

Why it matters

  1. Expands patient access. by allowing pharmacists at registered cannabis dispensaries to certify patients for medical cannabis, making it easier for patients to get certified without needing a separate doctor’s appointment.

  2. Requires pharmacists to complete a specific training. before certifying patients, ensuring they are knowledgeable about medical cannabis and patient care standards.

  3. Integrates pharmacists into the medical cannabis care team. , leveraging their expertise in medication management and potentially improving patient safety and treatment outcomes.

  4. Caps the certification fee at $25. when issued by a pharmacist, which could lower costs for patients seeking medical cannabis certification.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Medical cannabis dispensing pharmacists

    Pharmacists employed by registered organizations who supervise dispensing could recommend and certify patients during facility consultations after completing the required two-hour course and registering with the office.

  • Medical cannabis patients

    Registry identification cards would no longer expire automatically after one year, and certifications from eligible dispensing pharmacists would cost no more than $25.

  • Registered organizations operating cannabis dispensing facilities

    Their qualifying pharmacists could offer patient certification consultations within their facilities.

  • Watching

    Certifying practitioners

    The bill would replace the requirement to attest that all certification conditions are satisfied with an attestation that one is satisfied, and require a reasonable effort to consult the prescription monitoring registry rather than an absolute duty to consult it.

Headline styles

Let Pharmacists Certify Cannabis

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
James Skoufis

Senator · Senate District 42

Chair, Investigations And Government Operations

1 Co-sponsor

History

  1. Referred to health
  2. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A7795Assembly

Let Pharmacists Certify Cannabis

In Assembly Committee · Higher Education · Sponsor John T. McDonald III

Impact 6 · Moderate0% to pass

Full text

3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

6909

2023-2024 Regular Sessions

IN SENATE

May 15, 2023

Introduced by Sen. SKOUFIS -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT to amend the cannabis law, in relation to certification by pharmacists of patients using medical cannabis

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Section 30 of the cannabis law is amended to read as follows:

§ 30. Certification of patients. 1. A patient certification may only be issued if:

(a) the patient has a condition, which shall be specified in the patient's health care record, if applicable;

(b) the practitioner by training or experience is qualified to treat the condition;

(c) the patient is under the practitioner's continuing care for the condition; [and] or

(d) in the practitioner's professional opinion and review of past treatments, the patient is likely to receive therapeutic or palliative benefit from the primary or adjunctive treatment with medical use of cannabis for the condition.

2. The certification shall include:

(a) the name, date of birth and address of the patient;

(b) a statement that the patient has a condition and the patient is under the practitioner's care for the condition;

(c) a statement attesting that [all requirements] a requirement of subdivision one of this section [have] has been satisfied;

(d) the date; and

(e) the name, address, telephone number, and the signature of the certifying practitioner.

The board may require by regulation that the certification shall be on a form provided by the office. The practitioner may state in the certif-

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD11383-01-3

ication that, in the practitioner's professional opinion, the patient would benefit from medical cannabis only until a specified date. [The practitioner may state in the certification that, in the practitioner's professional opinion, the patient is terminally ill and that the certification shall not expire until the patient dies.]

3. In making a certification, the practitioner may consider the form of medical cannabis the patient should consume, including the method of consumption and any particular strain, variety, and quantity or percentage of cannabis or particular active ingredient, and appropriate dosage. The practitioner may state in the certification any recommendation or limitation the practitioner makes, in his or her professional opinion, concerning the appropriate form or forms of medical cannabis and dosage.

4. Every practitioner shall make a reasonable effort to consult the prescription monitoring program registry prior to making or issuing a certification, for the purpose of reviewing a patient's controlled substance history. For purposes of this section, a practitioner may authorize a designee to consult the prescription monitoring program registry on his or her behalf, provided that such designation is in accordance with section thirty-three hundred forty-three-a of the public health law.

5. The practitioner shall give the certification to the certified patient, and place a copy in the patient's health care record if the patient is under the practitioner's continuing care.

6. No practitioner shall issue a certification under this section for themselves.

7. A registry identification card based on a certification shall not expire [one year after the date the certification is signed by the practitioner], except as provided for in subdivision eight of this section.

8. (a) If the practitioner states in the certification that, in the practitioner's professional opinion, the patient would benefit from medical cannabis only until a specified earlier date, then the registry identification card shall expire on that date; and

(b) [if the practitioner states in the certification that in the practitioner's professional opinion the patient is terminally ill and that the certification shall not expire until the patient dies, then the registry identification card shall state that the patient is terminally ill and that the registration card shall not expire until the patient dies; (c) if the practitioner re-issues the certification to terminate the certification on an earlier date, then the registry identification card shall expire on that date and shall be promptly destroyed by the certified patient; (d) if the certification so provides, the registry identification card shall state any recommendation or limitation by the practitioner as to the form or forms of medical cannabis or dosage for the certified patient; and (e) the] The board [shall] may make regulations to implement this subdivision.

9. (a) A certification may be a special certification if, in addition to the other requirements for a certification, the practitioner certifies in the certification that the patient's condition is progressive and degenerative or that delay in the patient's certified medical use of cannabis poses a risk to the patient's life or health.

(b) The office shall create the form to be used for a special certification and shall make that form available to be downloaded from the office's website.

10. Prior to issuing a certification a practitioner must complete, at a minimum, a two-hour course as determined by the board in regulation. For the purposes of this article a person's status as a practitioner is deemed to be a "license" for the purposes of section thirty-three hundred ninety of the public health law and shall be subject to the same revocation process.

11. Notwithstanding any other law, rule, or regulation, any pharmacist employed by a registered organization and responsible for supervising the dispensing of medical cannabis within a cannabis dispensing facility shall be deemed an authorized practitioner able to recommend and certify patients upon consultation within such dispensing facility provided that such pharmacist has completed the two-hour course required by this section and registered with the office. The fee for such a certification shall not exceed twenty-five dollars.

§ 2. This act shall take effect immediately.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the cannabis law, in relation to certification by phar- macists of patients using medical cannabis

Purpose

To streamline patient certification for medical cannabis and alleviate the administrative burden for medical cannabis providers.

Summary of provisions

Section 1:Expands the criteria for when a practitioner may certify a patient and reduces the administrative burden for practitioners. This section also limits when a registry identification card expires and provides a process for pharmacists employed by registered organizations to become authorized practitioners.

Section 2: Sets the effective date.

Justification

Cannabis is an effective treatment for many medical conditions, illnesses, and diseases ranging from epilepsy to insomnia and anxiety. In 2018, the New York State Department of Health (DOH) recommended that medical professionals should be given broader discretion to prescribe medical cannabis so that patients can benefit from cannabis' unique properties. Nevertheless, for many patients, access to medical cannabis is curtailed by the administrative and patient certification hurdles that remain for medical providers. The New York Medical Cannabis Indus- try Association (MCIA) has emphasized that the medical program is "losing patients, practitioners, and jobs, and THE STATE IS forgoing millions in tax revenue" due to lack of support and failure to grow the program. Reducing the administrative burden for providers and expanding the criteria for certifying patients will help expand access to medical cannabis' benefits for patients and provide additional support for a critical industry that is strained due to burdensome regulations.

Legislative history

New bill.

Fiscal implications

None.

Effective date

This act shall take effect immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.